Translate
Acadia Pharmaceuticals Inc.
About
20.53USD-0.42 -2.00%
Closed • Updated at 13:54 GMT+00:00Market Cap$3.52B
P/E Ratio9.35
Volume27.7K
Beta1.09
RSI39.50
Gross Margin91.47%
Acadia Pharmaceuticals Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 6 2026
Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
Apr 30 2026
Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career
Apr 17 2026
Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual Meeting
Apr 15 2026
Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026
Apr 7 2026
Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome